Backed by more than two decades of research, Arthrosamid® has been proven safe and effective, providing long-lasting pain relief for knee osteoarthritis
Long-Lasting Pain Relief
A Minimally Invasive, Long-Lasting Treatment Arthrosamid® is a minimally invasive treatment for knee osteoarthritis that has demonstrated significant improvements in patients’ quality of life. In clinical studies, patients reported reduced pain as early as Week 4, with benefits lasting for more than 5 years
Leading the Way
First-in-Class Innovation Arthrosamid® is a first-in-class synovial implant administered as a single, minimally invasive outpatient procedure under local anesthesia, with ultrasound guidance
About Us
Arthos International is a Saudi company based in Riyadh and specializing in medical devices. It is Contura Orthopaedics’s nominee in the Kingdom of Saudi Arabia. Arthos International has a partnership agreement with Life Pillars Medical company for the distribution of Arthrosamid® in the Kingdom of Sausi Arabia.
Pr. Aziz Tnibar DVM, PhD, DECVS, DACVSMR, DECVSR, MBA is the General Manager of Arthos International. He is the pioneer in the research about the long-term efficacy, safety and mechanisms of action of the 2.5% Polyacrylamide hydrogel in the treatment of osteoarthritis.
